Tertiapin Q
|
- $330 - $850
- Product name: Tertiapin Q
- CAS: 910044-56-3
- MF: C106H175N35O24S4
- MW: 2452.01
- EINECS:
- MDL Number:MFCD02684419
- Synonyms:Teriapin Q;L-Lysinamide, L-alanyl-L-leucyl-L-cysteinyl-L-asparaginyl-L-cysteinyl-L-asparaginyl-L-arginyl-L-isoleucyl-L-isoleucyl-L-isoleucyl-L-prolyl-L-histidyl-L-glutaminyl-L-cysteinyl-L-tryptophyl-L-lysyl-L-lysyl-L-cysteinylglycyl-L-lysyl-, cyclic (3→14),(5→18)-bis(disulfide);Tertiapin-Q TFA
3 prices
Selected condition：
Brand
- ChemScene
- Sigma-Aldrich
Package
- 0.5MG
- 1mg
- 5mg
- ManufacturerChemScene
- Product numberCS-0029213
- Product descriptionTertiapin-Q 97.46%
- Packaging1mg
- Price$330
- Updated2021-12-16
- Buy
- ManufacturerChemScene
- Product numberCS-0029213
- Product descriptionTertiapin-Q 97.46%
- Packaging5mg
- Price$850
- Updated2021-12-16
- Buy
- ManufacturerSigma-Aldrich
- Product numberT1567
- Product descriptionTertiapin-Q trifluoroacetate salt ≥97% (HPLC)
- Packaging0.5MG
- Price$749
- Updated2025-07-31
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| ChemScene | CS-0029213 | Tertiapin-Q 97.46% | 1mg | $330 | 2021-12-16 | Buy |
| ChemScene | CS-0029213 | Tertiapin-Q 97.46% | 5mg | $850 | 2021-12-16 | Buy |
| Sigma-Aldrich | T1567 | Tertiapin-Q trifluoroacetate salt ≥97% (HPLC) | 0.5MG | $749 | 2025-07-31 | Buy |
Properties
Density :1.51±0.1 g/cm3(Predicted)
storage temp. :-20°C
form :Solid
color :White to off-white
Water Solubility :Soluble in water (2mg/ml)
Sequence :Ala-Leu-Cys-Asn-Cys-Asn-Arg-Ile-Ile-Ile-Pro-His-Gln-Cys-Trp-Lys-Lys-Cys-Gly-Lys-Lys-NH2 (Disulfide bridge: Cys3-Cys14, Cys5-Cys18)
storage temp. :-20°C
form :Solid
color :White to off-white
Water Solubility :Soluble in water (2mg/ml)
Sequence :Ala-Leu-Cys-Asn-Cys-Asn-Arg-Ile-Ile-Ile-Pro-His-Gln-Cys-Trp-Lys-Lys-Cys-Gly-Lys-Lys-NH2 (Disulfide bridge: Cys3-Cys14, Cys5-Cys18)
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|
